Bernardo Herrera‐Imbroda

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Fred Saad, Egils Vjaters, Neal D. Shore et al. · Journal of Clinical Oncology · 2024 · 102 citations · Full text

Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes

David Olmos, David Lorente, Daniel Alameda et al. · Annals of Oncology · 2024 · 63 citations · Full text

Anesthesia in Combination with Propofol Increases Disease-Free Survival in Bladder Cancer Patients Who Undergo Radical Tumor Cystectomy as Compared to Inhalational Anesthetics and Opiate-Based Analgesia

José Luis Guerrero Orriach, Aida Raigón Ponferrada, Alfredo Malo-Manso et al. · Oncology · 2020 · 60 citations

Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)

Nuria Romero-Laorden, Rebeca Lozano, Anuradha Jayaram et al. · British Journal of Cancer · 2018 · 42 citations · Full text

Percutaneous Tibial Nerve Stimulation in Treatment of Overactive Bladder: When Should Retreatment Be Started?

Cristobal Marchal, Bernardo Herrera‐Imbroda, Francisco Antuña et al. · Urology · 2011 · 34 citations

Urology, Interventional Pain Medicine, Health Sciences +8